These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 18669894)

  • 21. The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34(+) stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin.
    Proietto AI; Mittag D; Roberts AW; Sprigg N; Wu L
    Cell Mol Immunol; 2012 Nov; 9(6):446-54. PubMed ID: 23085949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and expression profiling of a human C-type lectin, structurally homologous to mouse dectin-2.
    Gavino AC; Chung JS; Sato K; Ariizumi K; Cruz PD
    Exp Dermatol; 2005 Apr; 14(4):281-8. PubMed ID: 15810886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of Dendritic Cell Function Using Clec9A-DTR Transgenic Mice.
    Tetlak P; Ruedl C
    Methods Mol Biol; 2016; 1423():275-89. PubMed ID: 27142024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
    Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
    EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of Clec9A on cDC1s associated with cytotoxic CD8
    Yan L; Wu X; Wu P; Su B; Xiong Y; Rao Y; Chen X; Huang W; Cui T
    Clin Immunol; 2022 Sep; 242():109082. PubMed ID: 35901921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced dendritic cell-induced immune responses mediated by the novel C-type lectin receptor mDCAR1.
    Kaden SA; Kurig S; Vasters K; Hofmann K; Zaenker KS; Schmitz J; Winkels G
    J Immunol; 2009 Oct; 183(8):5069-78. PubMed ID: 19786536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NKT Cell-Driven Enhancement of Antitumor Immunity Induced by Clec9a-Targeted Tailorable Nanoemulsion.
    Lam PY; Kobayashi T; Soon M; Zeng B; Dolcetti R; Leggatt G; Thomas R; Mattarollo SR
    Cancer Immunol Res; 2019 Jun; 7(6):952-962. PubMed ID: 31053598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
    Tsuji T; Matsuzaki J; Kelly MP; Ramakrishna V; Vitale L; He LZ; Keler T; Odunsi K; Old LJ; Ritter G; Gnjatic S
    J Immunol; 2011 Jan; 186(2):1218-27. PubMed ID: 21149605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141
    Pearson FE; Tullett KM; Leal-Rojas IM; Haigh OL; Masterman KA; Walpole C; Bridgeman JS; McLaren JE; Ladell K; Miners K; Llewellyn-Lacey S; Price DA; Tunger A; Schmitz M; Miles JJ; Lahoud MH; Radford KJ
    Clin Transl Immunology; 2020; 9(6):e1141. PubMed ID: 32547743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes.
    Huysamen C; Willment JA; Dennehy KM; Brown GD
    J Biol Chem; 2008 Jun; 283(24):16693-701. PubMed ID: 18408006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced CLEC9A expression in synovial tissue of psoriatic arthritis patients after adalimumab therapy.
    Ramos MI; Teunissen MB; Helder B; Aarrass S; de Hair MJ; van Kuijk AW; Gerlag DM; Tak PP; Lebre MC
    Rheumatology (Oxford); 2016 Sep; 55(9):1575-84. PubMed ID: 27179104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.
    Sancho D; Mourão-Sá D; Joffre OP; Schulz O; Rogers NC; Pennington DJ; Carlyle JR; Reis e Sousa C
    J Clin Invest; 2008 Jun; 118(6):2098-110. PubMed ID: 18497879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
    Unger WW; van Beelen AJ; Bruijns SC; Joshi M; Fehres CM; van Bloois L; Verstege MI; Ambrosini M; Kalay H; Nazmi K; Bolscher JG; Hooijberg E; de Gruijl TD; Storm G; van Kooyk Y
    J Control Release; 2012 May; 160(1):88-95. PubMed ID: 22366522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
    Adams EW; Ratner DM; Seeberger PH; Hacohen N
    Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression.
    McLellan AD; Kapp M; Eggert A; Linden C; Bommhardt U; Bröcker EB; Kämmerer U; Kämpgen E
    Blood; 2002 Mar; 99(6):2084-93. PubMed ID: 11877283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNGR-1(+) dendritic cells are located in meningeal membrane and choroid plexus of the noninjured brain.
    Quintana E; Fernández A; Velasco P; de Andrés B; Liste I; Sancho D; Gaspar ML; Cano E
    Glia; 2015 Dec; 63(12):2231-48. PubMed ID: 26184558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cell-associated lectin-1: a novel dendritic cell-associated, C-type lectin-like molecule enhances T cell secretion of IL-4.
    Ryan EJ; Marshall AJ; Magaletti D; Floyd H; Draves KE; Olson NE; Clark EA
    J Immunol; 2002 Nov; 169(10):5638-48. PubMed ID: 12421943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules.
    Ramakrishna V; Treml JF; Vitale L; Connolly JE; O'Neill T; Smith PA; Jones CL; He LZ; Goldstein J; Wallace PK; Keler T; Endres MJ
    J Immunol; 2004 Mar; 172(5):2845-52. PubMed ID: 14978085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells.
    Park HY; Tan PS; Kavishna R; Ker A; Lu J; Chan CEZ; Hanson BJ; MacAry PA; Caminschi I; Shortman K; Alonso S; Lahoud MH
    NPJ Vaccines; 2017; 2():31. PubMed ID: 29263886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.